New Cholesterol Therapy Cuts Bad Cholesterol by Nearly 50%, Potential Statin Alternative
Researchers from the University of Barcelona and University of Oregon develop a novel DNA-based cholesterol therapy that reduced LDL cholesterol by 47% in animal models, without statin-related side effects.